智通财经APP获悉，医渡科技(02158)午后涨超5%，截至发稿，涨4.23%，报6.65港元，成交额6946.76万港元。
消息面上，8月12日，医渡科技与广东医科大学附属医院联合研发的“脉管性疾病多模态专病数据库”及“美易智能体”，在广东省医院协会整形美容专业委员会2025年学术年会上正式亮相。据悉，“美易智能体”作为核心技术载体，由医渡科技与广附院整形外科共同研发，实现数据价值向临床应用的转化，是医渡科技大模型在医美领域的首次实践。
此外，在近日举办的2025数字疗法大会上，医渡科技作为深度参与海南“2+3”糖尿病管理项目的AI医疗企业参会，并公布了其在海南落地数字疗法的“成绩单”：自2023年启动试点以来，医渡科技与陵水县紧密合作解决了医患联通等问题。目前陵水县99.09%的在管患者已纳入系统化照护，空腹血糖达标率、糖化血红蛋白达标率从基线水平提升18.63%和4.68%，显著高于全省平均水平。继陵水后，公司将AI医疗创新成果逐步辐射至三亚、万宁、琼海、文昌等城市，并计划拓展高血压等更多慢性病种的数字疗法服务，预计2025年内公司将实现对超过10万区域患者的覆盖管理。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.